Overview: Digoxin TestIntroduction: The Digoxin Test measures digoxin levels to monitor heart failure treatment, preventing irregular heartbeats. Following 2023 ACC/AHA guidelines, it uses an immunoassay for high sensitivity, aiding in drug monitoring. This test is critical for guiding dosing, preventing toxicity, and improving outcomes in toxicology for patients on digoxin therapy.
Other Names: Digoxin Assay, Cardiac Glycoside Test.
FDA Status: Laboratory-developed test (LDT), meeting toxicology standards for diagnostic accuracy.
Historical Milestone: Digoxin testing began in the 1970s with heart failure research. Immunoassays emerged in the 1980s, and by the 2000s, high-sensitivity assays improved accuracy.
Purpose: Monitors digoxin levels, guides dosing, and prevents toxicity in patients with heart failure or irregular heartbeats.
Test Parameters: 1. Digoxin
Pretest Condition: Fasting for 10-12 hours required to stabilize drug levels. Collect serum or plasma at least 6 hours after the last dose. Report symptoms like nausea or arrhythmias, and list medications.
Specimen: 2-5 mL serum (SST) or 2-4 mL plasma (EDTA). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document heart failure, arrhythmias, or symptoms like nausea. Include current medications, especially cardiac drugs.
Consent: Written consent required, detailing the tests purpose, implications for dosing, and potential need for therapy adjustments.
Procedural Considerations: Uses an immunoassay to measure digoxin levels. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Improper timing or drug interactions can affect results. Hemolysis may degrade samples.
Clinical Significance: Abnormal digoxin levels indicate need for dose adjustment to prevent toxicity or inefficacy. Therapeutic levels support ongoing monitoring.
Specialist Consultation: Consult a cardiologist for result interpretation.
Additional Supporting Tests: Electrolyte panel, kidney function tests, or ECG to monitor digoxin effects.
Test Limitations: Results may vary with drug interactions. Clinical correlation is required.
References: ACC/AHA Heart Failure Guidelines, 2023; Circulation, Yancy CW, 2022.
